Cline Scientific receives Decision to Grant for StemCART in Europe

The patent application is titled "A method for providing a cartilage implant with chondrocytes". The decision will take effect from the 14th of June 2023.

The notice of allowance for this patent was received from EPO and a press release was sent out in April.

More about StemCART

StemCART is a preclinical Advanced Therapy Medicinal Product (ATMP) that aims to revolutionize the treatment of cartilage damage for patients worldwide.

 

For more information, please contact:

Hanne Evenbratt, Interim CEO and VP – Research & Development

Email: hanne.evenbratt@clinescientific.com

Phone: +46 704 88 79 23

 

Datum 2023-05-23, kl 14:50
Källa Cision
Bifogade filer
Ungdomsdeal - 200 kr ! Just nu får alla nya kunder mellan 18 och 25 år 200 kr gratis när man skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra läge att testa Nordnet!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet